MiniMed (Nasdaq:MMED) announced today that it launched two insulin delivery platforms with the Instinct sensor made by Abbott in Europe. The Northridge, California-based former Medtronic Diabetes unit launched its MiniMed 780G automated insulin delivery system integrated with Instinct, along with the MiniMed Go system paired with the Instinct Go sensor. Both sensors, made by Abbott […]
Drug-Device Combinations
Insulet has a new chief R&D officer
Insulet (Nasdaq:PODD) announced today on social media that it appointed Dr. Divakar Ramakrishnan as its new chief R&D officer. In a LinkedIn post, the company said Ramakrishnan will lead its R&D organization. His focus centers around strengthening Insulet’s capabilities in delivering innovation around the world. Ramakrishnan joins as the company continues to advance its automated […]
MiniMed begins miniature Flex pump rollout in US
MiniMed (Nasdaq:MMED) announced today that it kicked off its first commercial launch of its Flex automated insulin delivery system in the U.S. The launch comes a few months after the system picked up FDA clearance in March. Northridge, California-based MiniMed, the former Medtronic Diabetes unit, designed Flex, its smallest insulin pump yet, as its first […]
Embecta names new SVP and president, North America
Embecta (Nasdaq:EMBC) announced that it appointed Nimish Muzumdar as its new SVP and president, North America. Muzumdar holds responsibility for leading the company’s U.S. and Canada commercial teams, executing the region’s long-term growth strategy. He reports to Chair, President and CEO, Dev Kurdikar, and serves on the Embecta operating team. His appointment went into effect […]
FDA clears Dexcom Stelo over-the-counter CGM for children
Dexcom (Nadsaq:DXCM) has received FDA clearance for its Stelo over-the-counter (OTC) continuous glucose monitor (CGM) for children. The FDA said in a news release that it cleared Stelo for people two years of age and older who do not use insulin. It became the first OTC CGM system granted clearance in March 2024, initially getting […]
Airiver treats first patient in drug-coated balloon study for chronic rhinosinusitis
Airiver Medical today announced the successful treatment of the first patient in a pivotal clinical trial of its drug-coated balloon (DCB). The first patient received treatment for chronic rhinosinusitis (CRS) in its RESTORE-2 U.S. pivotal clinical trial. It evaluates the Brooklyn Park, Minnesota-based company’s Airiver ESSpand sinus DCB. Dr. Andrew Gould treated the first patient […]
Senseonics, Welldoc partner on next-gen Eversense 365 app development
Senseonics (NYSE:SENS) and Welldoc today announced a strategic partnership to develop a new custom mobile application for Eversense 365. Eversense 365 is a 365-day implantable continuous glucose monitor (CGM) that rests under the skin for the duration of a year. Users can change its external, silicone-based adhesive daily with almost no skin reactions. The implant […]
The biggest diabetes tech news out of ADA 2026
The biggest names in diabetes tech gathered in New Orleans last weekend for the American Diabetes Association’s 86th Scientific Sessions (ADA 2026). Clinical findings supporting next-generation automated insulin delivery platforms, continuous glucose monitors (CGMs) and all kinds of other technologies were on display in New Orleans. BTIG analysts Marie Thibault, Alexandra Pang and Sam Eiber […]
Beta Bionics real-world data shows 25% time in range improvement with iLet
Beta Bionics (Nasdaq:BBNX) said real-world data discussed last weekend highlighted the impact of its iLet Bionic Pancreas platform. The company said conversations with clinicians at the American Diabetes Association Scientific Sessions (ADA 2026) in New Orleans covered improved outcomes and easier follow-up visits. The Irvine, California-based company said outcomes demonstrated how iLet supports diabetes care […]
CeQur closes $100M Series E to support mealtime insulin patch
CeQur announced today that it closed a $100 million Series E financing round to support its mealtime insulin delivery technology. Horw, Switzerland-based CeQur develops the Simplicity mealtime insulin patch pump system. The wearable, disposable bolus insulin delivery system was developed as, essentially, a wearable insulin pen. CeQur began a pilot commercial launch for the FDA-cleared […]
